Aion Therapeutic Inc.
Aion Therapeutic Inc. (ANTCF) Revenue
Annual & quarterly revenue history · segment & region breakdown
ANTCF · revenue · updated Jun 9, 2026
Core revenue metrics
Trailing 12 monthsAion Therapeutic Inc. trailing twelve-month (TTM) revenue is $0.00B, an increase of 0.00% year-over-year from — in FY.
Revenue trend
– · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Aion Therapeutic Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Aion Therapeutic Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Aion Therapeutic Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
ANTCF revenue · 4 questionsANTCF's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 0.00% year-over-year from — in FY.
▸ Source: FMP · Aion Therapeutic Inc. SEC filings · GAAP · Aion Therapeutic Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026